Literature DB >> 30190959

Preventing hepatocellular carcinoma: the crucial role of chronic hepatitis B monitoring and antiviral treatment.

Mehlika Toy1,1, Utkan Demirci2,2, Samuel So1,1.   

Abstract

Entities:  

Year:  2014        PMID： 30190959      PMCID： PMC6095182          DOI： 10.2217/hep.14.10

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  15 in total

1.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

2.  [Principles and practice of mass screening for disease].

Authors:  J M Wilson; Y G Jungner
Journal:  Bol Oficina Sanit Panam       Date:  1968-10

3.  Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care.

Authors:  Blaire E Burman; Nizar A Mukhtar; Brian C Toy; Tung T Nguyen; Alice Hm Chen; Albert Yu; Peter Berman; Hali Hammer; Daniel Chan; Charles E McCulloch; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2013-09-20       Impact factor: 3.199

4.  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Authors:  Patrick Marcellin; Edward Gane; Maria Buti; Nezam Afdhal; William Sievert; Ira M Jacobson; Mary Kay Washington; George Germanidis; John F Flaherty; Raul Aguilar Schall; Jeffrey D Bornstein; Kathryn M Kitrinos; G Mani Subramanian; John G McHutchison; E Jenny Heathcote
Journal:  Lancet       Date:  2012-12-10       Impact factor: 79.321

5.  Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.

Authors:  Jin-De Chen; Hwai-I Yang; Uchenna H Iloeje; San-Lin You; Sheng-Nan Lu; Li-Yu Wang; Jun Su; Chien-An Sun; Yun-Fan Liaw; Chien-Jen Chen
Journal:  Gastroenterology       Date:  2010-01-28       Impact factor: 22.682

6.  Institute of Medicine recommendations for the prevention and control of hepatitis B and C.

Authors:  Abigail E Mitchell; Heather M Colvin; R Palmer Beasley
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

7.  Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Authors:  Yun-Fan Liaw; Joseph J Y Sung; Wan Cheng Chow; Geoffrey Farrell; Cha-Ze Lee; Hon Yuen; Tawesak Tanwandee; Qi-Min Tao; Kelly Shue; Oliver N Keene; Jonathan S Dixon; D Fraser Gray; Jan Sabbat
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

8.  Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

Authors:  A Singal; M L Volk; A Waljee; R Salgia; P Higgins; M A M Rogers; J A Marrero
Journal:  Aliment Pharmacol Ther       Date:  2009-04-08       Impact factor: 8.171

9.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Authors:  Sean F Altekruse; Katherine A McGlynn; Marsha E Reichman
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more
  1 in total

1.  Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model.

Authors:  Grace X Ma; Lin Zhu; Wenyue Lu; Yin Tan; Jade Truehart; Cicely Johnson; Elizabeth Handorf; Minhhuyen T Nguyen; Ming-Chin Yeh; Min Qi Wang
Journal:  Int J Environ Res Public Health       Date:  2022-04-12       Impact factor: 4.614
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.